Legal & General Group
DTIL icon

Legal & General Group’s Precision BioSciences DTIL Stock Holding History

Legal & General Group’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-146
Closed -$6K – 3423
2022
Q3 		$6K Sell
146
-2,058
-93% -$97.8K ﹤0.01% 3390
2022
Q2 		$106K Buy
2,204
+1,301
+144% +$76.4K ﹤0.01% 2840
2022
Q1 		$83K Hold
903
– – ﹤0.01% 2912
2021
Q4 		$200K Buy
903
+4
+0.4% +$1.12K ﹤0.01% 2724
2021
Q3 		$311K Buy
899
+310
+53% +$105K ﹤0.01% 2557
2021
Q2 		$221K Buy
589
+376
+177% +$113K ﹤0.01% 2511
2021
Q1 		$66K Sell
213
-18
-8% -$6.3K ﹤0.01% 2740
2020
Q4 		$58K Buy
231
+43
+23% +$10.5K ﹤0.01% 2760
2020
Q3 		$35K Sell
188
-59
-24% -$11.7K ﹤0.01% 2797
2020
Q2 		$62K Buy
247
+49
+25% +$10.7K ﹤0.01% 2669
2020
Q1 		$36K Sell
198
-49
-20% -$12.8K ﹤0.01% 2702
2019
Q4 		$103K Buy
247
+197
+394% +$61.9K ﹤0.01% 2583
2019
Q3 		$13K Hold
50
– – ﹤0.01% 3226
2019
Q2 		$20K Sell
50
-83
-62% -$33.4K ﹤0.01% 3191
2019
Q1 		$70K Buy
+133
New +$70.6K ﹤0.01% 2607

Other funds holding DTIL

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Legal & General Group's DTIL Position: Q4 2022 in Review

Legal & General Group sold out of Precision BioSciences (DTIL) in Q4 2022, closing a stake of 146 shares — an estimated $6K sold.

Legal & General Group first reported a position in DTIL in Q1 2019 and held it in 15 quarters. The position peaked at $311K in Q3 2021. 100 funds tracked by Wall St. Rank hold DTIL as of Q4 2022.

  • Legal & General Group reported no remaining Precision BioSciences position as of Q4 2022 after selling out during the quarter.
  • Legal & General Group sold 146 Precision BioSciences shares in Q4 2022, an estimated $6K.
  • Legal & General Group first reported a position in Precision BioSciences in Q1 2019 and held it in 15 quarters.
  • Legal & General Group's Precision BioSciences position peaked at $311K in Q3 2021.
  • 100 funds tracked by Wall St. Rank held Precision BioSciences as of Q4 2022.

Based on Legal & General Group's 13F filing for Q4 2022, filed 14 Feb 2023.